Invention Grant
- Patent Title: Polycyclic indoline and indolenine compounds
-
Application No.: US15569186Application Date: 2016-04-29
-
Publication No.: US10253024B2Publication Date: 2019-04-09
- Inventor: Xiang Wang , Patrick Barbour
- Applicant: The Regents of the University of Colorado, a body corporate
- Applicant Address: US CO Denver
- Assignee: The Regents of the University of Colorado, a body corporate
- Current Assignee: The Regents of the University of Colorado, a body corporate
- Current Assignee Address: US CO Denver
- Agency: Hamilton DeSanctis & Cha, LLP
- Agent Don D. Cha
- International Application: PCT/US2016/030233 WO 20160429
- International Announcement: WO2016/176634 WO 20161103
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/10 ; C07D471/18 ; A61P31/04 ; A61K31/437 ; A61K45/06
Abstract:
The present invention relates to indoline and indolenine alkaloid compounds. In particular, indoline and indolenine alkaloid compounds of the invention have antibacterial activity and/or are capable of re-sensitizing the susceptibility of methicillin-resistant S. aureus to a β-lactam antibiotic. The present invention also relates to a method for producing and using the same.
Public/Granted literature
- US20180148442A1 Polycyclic Indoline and Indolenine Compounds Public/Granted day:2018-05-31
Information query
